Tan P L, Borman G B, Wigley R D
Rheumatol Int. 1981;1(3):147-9. doi: 10.1007/BF00541261.
The American Rheumatism Association (ARA) clinical criteria have been tested in systemic lupus erythematosus (SLE), progressive systemic sclerosis, polyarteritis nodosa and polymyositis/dermatomyositis. Hospital admissions from a defined population over the same period were studied. Increased weighting of the scores for the features showing the greatest specificity is suggested. These features are discoid lupus, alopecia, photosensitivity, LE cells and/or antinuclear antibody (ANA) and oral ulcers. Inclusion of histological evidence increased the sensitivity of the SLE scores.
美国风湿病协会（ARA）的临床标准已在系统性红斑狼疮（SLE）、进行性系统性硬化症、结节性多动脉炎和多发性肌炎/皮肌炎中进行了测试。对同一时期特定人群的住院情况进行了研究。建议对显示出最大特异性的特征的评分增加权重。这些特征包括盘状狼疮、脱发、光敏性、狼疮细胞和/或抗核抗体（ANA）以及口腔溃疡。纳入组织学证据提高了SLE评分的敏感性。
